Canadian Technology Stocks and Startups
Yesterday, Tekmira (TSX:TKM) announced that it had settled the ongoing litigiation between it and Alnylam Pharmaceuticals. The Burnaby-based company said it had signed a new licensing agreement that provides clarity on all intellectual property and licensing issues between the pair. Tekmira says that as a result of the resolution it will receive $65-million within 10 [...]
On Tuesday, Tekmira (TSX:TKM) announced that the temporary stop-work order announced on August 6th, with respect to its TKM-Ebola program, was lifted by the U.S. Department of Defense. Tekmira CEO Mark Murray said:”We are pleased that our productive collaboration with the U.S. DoD’s transformational medical technologies program will continue. As we recommence our work, we [...]
Last week, Alnylam Pharmaceuticals (NASDAQ:ALNY) announced that it reported positive results from a seventeen patient Phase I study testing siRNA-LNP (lipid nanoparticle, small interefering RNA) drug ALN-TTR02 as a therapy for the orphan medical indication TTR-amyloidosis (TTR-A). The study used Tekmira’s (TSX:TKM) LNP delivery platform. Byron Capital’s Douglas Loe says that while the trial was [...]
On Tuesday, Tekmira (TSX:TKM) reported its Q1, 2012 results. Revenue of $3.6-million was a dip from the company’s topline of $4.3-million in the first quarter of 2011. The company’s net loss of $3.2-million, however, was in line with Q1, 2011′s net loss of $3.1-million. Byron Capital’s Douglas Loe says the quarter met his expectations, with [...]
There are many people who believe Canadian technology stocks are undervalued. Of course, as John Maynard Keynes famously quipped, markets can remain irrational longer than you can remain solvent. Still, with a massive exodus from commodities now fully underway, is it just a matter of time before money starts flowing into Canadian technology stocks, driving [...]
In January, we looked back at the Canadian tech stocks that had an exceptional 2010, capped off by the selection of Glentel as Canadian Tech Stock of the Year and Mark Therier of SXC Health as Canadian Tech Stock exec of the Year. This month we look forward. No we don’t have a crystal ball, [...]
It’s been nearly a century since Canada’s greatest achievement in biotech took place; the discovery of insulin by Frederick Banting and his assistant Charles Best, in 1922. While nothing since has matched that miraculous feat, which has saved countless millions of lives, it’s not like Canada has been sitting still in the meantime. Canadian researchers [...]
